This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Are Options Traders Betting on a Big Move in InnovAge Holding Stock?
by Zacks Equity Research
Investors need to pay close attention to INNV stock based on the movements in the options market lately.
INNVNegative Net Change
medical
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
by Zacks Equity Research
WST is riding on surging GLP-1 demand and HVP expansion. Yet, pricing pressure, tariff risks and contract manufacturing headwinds cloud the near-term outlook.
CAHPositive Net Change COONegative Net Change WSTPositive Net Change PAHCNegative Net Change
medical medical-devices
Humana Partners With Atlas to Enhance Cancer Care for Seniors
by Zacks Equity Research
HUM teams up with Atlas Oncology to make a cancer care model available for its eligible MA members in TN and MS starting in 2026.
REGNNegative Net Change BMRNPositive Net Change HUMPositive Net Change ENSGNegative Net Change
medical
Will Positive Data on Camzyos Strengthen BMY's Cardiovascular Portfolio?
by Ekta Bagri
BMY reports positive late-stage data for Camzyos in adolescents with oHCM, expanding its cardiovascular outlook amid pipeline setbacks and rising competition.
BMYPositive Net Change JNJPositive Net Change CYTKPositive Net Change
biotechnology biotechs medical pharmaceuticals
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery
by Zacks Equity Research
Kestra teams up with Biobeat in an exclusive deal, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery.
BSXNegative Net Change ATRCPositive Net Change PAHCNegative Net Change KMTSPositive Net Change
medical medical-devices
Reasons to Retain TransMedics Stock in Your Portfolio for Now
by Zacks Equity Research
TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.
BSXNegative Net Change IDXXNegative Net Change STEPositive Net Change TMDXNegative Net Change
medical medical-devices
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety
by Zacks Equity Research
BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.
BSXNegative Net Change BAXPositive Net Change IDXXNegative Net Change STEPositive Net Change
medical medical-devices
PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific
by Zacks Equity Research
Pacira BioSciences teams up with LG Chem to expand Exparel across Asia-Pacific, unlocking royalties and new revenue channels to support international growth.
ALKSPositive Net Change FOLDPositive Net Change PCRXPositive Net Change KRYSNegative Net Change
biotechnology biotechs medical pharmaceuticals
Curaleaf Announces Delaware Domestication Plan: How to Play the Stock?
by Sundeep Ganoria
CURLF's Delaware domestication plan could streamline governance and enhance capital market flexibility as U.S. pressure persists and international growth builds.
CGCNegative Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical pot-stocks
4 Value Stocks to Buy As Wall Street Weighs Trump Policies
by Sumit Singh
As markets reel from policy uncertainty, UHS, PNC, GPN, and BMRN emerge as compelling value picks with strong cash flow.
PNCNegative Net Change BMRNPositive Net Change UHSNegative Net Change GPNPositive Net Change
business-services finance medical
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
by Zacks Equity Research
EW benefits from strong TAVR and TMTT momentum, but macro pressures and FX headwinds cloud the near-term outlook.
BSXNegative Net Change EWNegative Net Change PAHCNegative Net Change NVSTPositive Net Change
medical medical-devices
What's Next for Tilray Brands After Posting Record Q2 Revenues?
by Moumi Mondal
TLRY posts record Q2 revenues of $217.5M as international cannabis and distribution strength outweighs beverage headwinds.
CRONNegative Net Change CGCNegative Net Change TLRYPositive Net Change
medical medical-devices
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
by Indrajit Bandyopadhyay
ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.
ISRGNegative Net Change STXSPositive Net Change ZBHPositive Net Change
medical medical-devices
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
by Zacks Equity Research
TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for long-term holders.
BSXNegative Net Change TMOPositive Net Change PAHCNegative Net Change NVSTPositive Net Change
medical
New Strong Sell Stocks for Jan. 14
by Zacks Equity Research
APRE, CULP and PSKY have been added to the Zacks Rank #5 (Strong Sell) List on Jan.13, 2026.
CULPPositive Net Change APRENegative Net Change PSKYNegative Net Change
medical
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts
by Indrajit Bandyopadhyay
ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.
BSXNegative Net Change ANGOPositive Net Change MDTPositive Net Change
medical medical-devices
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook
by Zacks Equity Research
ADMA expects 2025 revenues of approximately $510-$511 million, raising 2026 guidance on strong Asceniv demand and margin expansion.
FOLDPositive Net Change ADMAPositive Net Change KRYSNegative Net Change
biotechnology biotechs medical pharmaceuticals
ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon
by Zacks Equity Research
AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal, cutting U.S. prices while expanding its oncology pipeline.
BMYPositive Net Change PFEPositive Net Change MRKPositive Net Change ABBVPositive Net Change
biotechs medical pharmaceuticals
Brookdale Senior 4Q25 Sneak Peek: Occupancy Volume Rises to 82.5%
by Zacks Equity Research
BKD's 4Q25 weighted average occupancy rises to 82.5%, capping a year of gains as resident fees climb.
BSXNegative Net Change UHSNegative Net Change BKDNegative Net Change ENSGNegative Net Change
medical
NTRA & NVDA Partner to Improve AI Models for Precision Medicine
by Zacks Equity Research
Natera teams up with NVIDIA to train multimodal AI models, aiming to improve precision care through faster, scalable analysis of complex medical data.
NVDANegative Net Change VCYTNegative Net Change CDNAPositive Net Change NTRAPositive Net Change
medical medical-devices
Novo Nordisk Soars 19% in a Month: How Should You Play the Stock?
by Ahan Chakraborty
NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy, the first GLP-1 pill for obesity and cardiovascular risk reduction.
NVONegative Net Change LLYNegative Net Change VKTXPositive Net Change
biotechnology biotechs medical pharmaceuticals
Are Options Traders Betting on a Big Move in Varex Imaging Stock?
by Zacks Equity Research
Investors need to pay close attention to VREX stock based on the movements in the options market lately.
VREXPositive Net Change
medical
Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings?
by Sundeep Ganoria
ABBV's oncology unit is expected to post nearly 4% Q4 sales growth, as newer drugs offset weakness from declining Imbruvica demand.
AZNPositive Net Change PFEPositive Net Change MRKPositive Net Change ABBVPositive Net Change
biotechs earnings medical pharmaceuticals
Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?
by Zacks Equity Research
Investors need to pay close attention to USPH stock based on the movements in the options market lately.
USPHPositive Net Change
medical
Health & Fitness Stocks Positioned for Strong 2026 Growth
by Nilanjan Choudhury
UNFI, COCO, DOCS and PTON are tapping into the $11T wellness boom with tech, nutrition, and fitness-driven growth.
AMZNNegative Net Change AAPLNegative Net Change COCONegative Net Change UNFIPositive Net Change PTONNegative Net Change DOCSNegative Net Change
consumer-discretionary consumer-staples medical